Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

dystrotelin Inhibitors

Dystrotelin inhibitors are a class of chemical compounds that specifically target and inhibit dystrotelin, a protein believed to be involved in cytoskeletal organization and cellular structural integrity. Dystrotelin is associated with actin-binding activities, contributing to the stabilization and maintenance of the cytoskeleton. This protein is important for cellular processes such as migration, adhesion, and the regulation of cell shape, particularly in muscle cells and other highly structured cell types. Inhibitors of dystrotelin function by interfering with its binding to actin or by altering its conformational states, thereby disrupting its role in cytoskeletal assembly and maintenance.

Dystrotelin inhibitors may include small molecules or peptides that interact directly with the actin-binding domains of the protein. These compounds are often designed to mimic the natural substrates or interaction partners of dystrotelin, allowing them to compete with these molecules at key binding sites. By inhibiting dystrotelin's interaction with the actin cytoskeleton, these inhibitors can alter cellular mechanics and provide insights into the protein's role in maintaining structural integrity under various conditions. The disruption of dystrotelin function by these inhibitors serves as a valuable tool in research on cytoskeletal dynamics, helping to uncover the molecular mechanisms by which cells regulate their shape, motility, and internal organization. Additionally, the study of dystrotelin inhibitors allows researchers to explore the broader impact of actin-binding proteins in cellular architecture and function.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Sirolimus binds to the mTOR complex and inhibits its activity, which can result in the downregulation of protein synthesis, including possibly "dystrotelin".

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could downregulate AKT/mTOR signaling, potentially leading to reduced protein synthesis including "dystrotelin".

WYE-125132

1144068-46-1sc-364651
sc-364651A
10 mg
50 mg
$510.00
$1536.00
(0)

WYE-125132 is a potent inhibitor of mTOR, which could decrease the expression of proteins regulated by this pathway.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Palbociclib is a CDK4/6 inhibitor, which could lead to cell cycle arrest and potentially downregulate proteins like "dystrotelin".

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

Olaparib, a PARP inhibitor, may influence various cellular processes including the expression of certain proteins.

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$62.00
$225.00
$779.00
24
(1)

Nutlin-3 disrupts the interaction between p53 and MDM2, which could lead to changes in gene expression profiles.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

SB431542 is an inhibitor of the TGF-β receptor, affecting downstream signaling and possibly altering protein expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, potentially affecting transcription factors regulated by JNK and altering protein expression.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK inhibitor, which might lead to the downregulation of ERK signaling and affect gene expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is another MEK inhibitor, known to block ERK phosphorylation and thus could influence protein expression.